EWP
ROIV icon

Elevation Wealth Partners’s Roivant Sciences ROIV Stock Holding History

Elevation Wealth Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07K Buy
115
+40
+53% +$1.18K ﹤0.01% 1067
2026
Q1 		$2.08K Hold
75
– – ﹤0.01% 902
2025
Q4 		$1.63K Buy
+75
New +$1.48K ﹤0.01% 814

Other funds holding ROIV

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PDM
Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CA
Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.2B AUM 13.59% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Elevation Wealth Partners's ROIV Position: Q2 2026 in Review

Elevation Wealth Partners increased its Roivant Sciences (ROIV) stake by 53% in Q2 2026, buying an estimated $1.18K and bringing the position to 115 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Elevation Wealth Partners first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. 126 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Elevation Wealth Partners held 115 shares of Roivant Sciences worth $4.07K as of Q2 2026.
  • Elevation Wealth Partners bought 40 Roivant Sciences shares in Q2 2026, an estimated $1.18K.
  • Roivant Sciences made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #1067 holding.
  • Elevation Wealth Partners first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • 126 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.